Intracranial aneurysm rupture score may correlate to the risk of rebleeding before treatment of ruptured intracranial aneurysms.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 05 01 2019
accepted: 24 04 2019
pubmed: 1 5 2019
medline: 14 1 2020
entrez: 1 5 2019
Statut: ppublish

Résumé

Aneurysm rebleeding after rupture can result in a catastrophic outcome with high mortality and morbidity. In this study, we evaluated the correlation of IARS (intracranial aneurysm rupture score) and aneurysm rebleeding. The aim of this study was to explore the clinical utility of IARS for better clinical decision-making. The patients with ruptured intracranial aneurysms between January 2017 and September 2018 were reviewed. Propensity scoring match was performed to construct a cohort. The morphological and hemodynamic parameters were obtained. The difference between stable aneurysms and rebleeding aneurysms was compared. Subsequently, the correlation of IARS and aneurysm rebleeding was studied. The matching process constructed a cohort, including 5 rebleeding aneurysms and 15 stable aneurysms. By comparing the difference between stable aneurysms and rebleeding aneurysms, the statistical significance was found in diameter of neck (p = 0.036), aspect ratio (p = 0.004) and size ratio (p = 0.029), normalized wall shear stress average (p = 0.026), low shear area ratio (p = 0.028), oscillatory shear index (OSI) (p = 0.031), and deviated angle (p = 0.025). The IARS here had a strong correlation with the aneurysm rebleeding, and the interval from the first bleeding to the rebleeding tended to shorten with the increase of IARS (R = 0.715, p = 0.027). IARS had a good predicting value for the aneurysm rebleeding (area under the curve = 0.756, p < 0.001). Based on this preliminary study, intracranial aneurysm rupture score may correlate to the rebleeding in ruptured aneurysms. For ruptured aneurysms with high IARS scores, surgery should be given priority, and medical treatment is not recommended.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Aneurysm rebleeding after rupture can result in a catastrophic outcome with high mortality and morbidity. In this study, we evaluated the correlation of IARS (intracranial aneurysm rupture score) and aneurysm rebleeding. The aim of this study was to explore the clinical utility of IARS for better clinical decision-making.
METHOD METHODS
The patients with ruptured intracranial aneurysms between January 2017 and September 2018 were reviewed. Propensity scoring match was performed to construct a cohort. The morphological and hemodynamic parameters were obtained. The difference between stable aneurysms and rebleeding aneurysms was compared. Subsequently, the correlation of IARS and aneurysm rebleeding was studied.
RESULTS RESULTS
The matching process constructed a cohort, including 5 rebleeding aneurysms and 15 stable aneurysms. By comparing the difference between stable aneurysms and rebleeding aneurysms, the statistical significance was found in diameter of neck (p = 0.036), aspect ratio (p = 0.004) and size ratio (p = 0.029), normalized wall shear stress average (p = 0.026), low shear area ratio (p = 0.028), oscillatory shear index (OSI) (p = 0.031), and deviated angle (p = 0.025). The IARS here had a strong correlation with the aneurysm rebleeding, and the interval from the first bleeding to the rebleeding tended to shorten with the increase of IARS (R = 0.715, p = 0.027). IARS had a good predicting value for the aneurysm rebleeding (area under the curve = 0.756, p < 0.001).
CONCLUSION CONCLUSIONS
Based on this preliminary study, intracranial aneurysm rupture score may correlate to the rebleeding in ruptured aneurysms. For ruptured aneurysms with high IARS scores, surgery should be given priority, and medical treatment is not recommended.

Identifiants

pubmed: 31037508
doi: 10.1007/s10072-019-03916-1
pii: 10.1007/s10072-019-03916-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1683-1693

Subventions

Organisme : National Natural Science Foundation of China
ID : 81471210
Organisme : National Natural Science Foundation of China
ID : 81671129
Organisme : National key research and development program
ID : 2016YFC1301800

Références

JAMA. 1999 Dec 1;282(21):2035-42
pubmed: 10591386
Neurosurgery. 2006 Jul;59(1):21-7; discussion 21-7
pubmed: 16823296
Lancet Neurol. 2007 Jun;6(6):487-93
pubmed: 17509483
AJNR Am J Neuroradiol. 2008 Oct;29(9):1761-7
pubmed: 18599576
Neurosurgery. 2008 Aug;63(2):185-96; discussion 196-7
pubmed: 18797347
Neurosurgery. 2009 Apr;64(4):622-30; discussion 630-1
pubmed: 19349824
Lancet Neurol. 2009 Jul;8(7):635-42
pubmed: 19501022
Stroke. 2010 May;41(5):916-20
pubmed: 20378866
Stroke. 2011 Jan;42(1):144-52
pubmed: 21106956
Stroke. 2011 Mar;42(3):669-74
pubmed: 21257823
Acta Neuropathol. 2012 Jun;123(6):773-86
pubmed: 22249619
Stroke. 2012 Jun;43(6):1711-37
pubmed: 22556195
Acta Neurochir Suppl. 2013;115:275-8
pubmed: 22890680
CNS Neurosci Ther. 2012 Nov;18(11):895-902
pubmed: 22966850
Ann Biomed Eng. 2013 Jul;41(7):1411-27
pubmed: 23229281
AJNR Am J Neuroradiol. 2014 Jul;35(7):1254-62
pubmed: 23598838
J Neurol Surg A Cent Eur Neurosurg. 2013 Sep;74(5):294-302
pubmed: 23700168
Curr Neurovasc Res. 2013 Aug;10(3):247-55
pubmed: 23713738
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):56-9
pubmed: 23813741
Stroke. 2013 Oct;44(10):2926-9
pubmed: 23929749
J Clin Neurosci. 2014 Jan;21(1):28-32
pubmed: 24120708
Transl Stroke Res. 2014 Jun;5(3):338-46
pubmed: 24323713
Transl Stroke Res. 2014 Apr;5(2):167-73
pubmed: 24323717
Transl Stroke Res. 2014 Apr;5(2):190-8
pubmed: 24323732
World Neurosurg. 2014 Feb;81(2):206-8
pubmed: 24355516
J Neurosurg. 2015 Feb;122(2):383-91
pubmed: 25403841
J Biomech. 2014 Dec 18;47(16):3882-90
pubmed: 25446264
Anesthesiology. 2015 Feb;122(2):241-75
pubmed: 25545654
J Neurosurg. 2015 Apr;122(4):921-8
pubmed: 25658785
BMJ Open. 2015 Jun 12;5(6):e007795
pubmed: 26070797
J Neurol Surg A Cent Eur Neurosurg. 2016 May;77(3):207-21
pubmed: 26807617
Medicine (Baltimore). 2016 Mar;95(11):e3028
pubmed: 26986118
Front Neurol. 2016 Dec 05;7:219
pubmed: 27994571
Stroke. 2017 Apr;48(4):880-886
pubmed: 28265012
J Neurosurg. 2018 Oct;129(4):854-860
pubmed: 29099302
J Proteomics. 2018 Jun 30;182:45-52
pubmed: 29729990
Front Neurosci. 2018 Sep 05;12:596
pubmed: 30233292
Lancet. 2018 Oct 6;392(10154):1257-1268
pubmed: 30319113
Stroke. 1988 Oct;19(10):1250-6
pubmed: 3176085
J Neurosurg. 1987 Sep;67(3):329-32
pubmed: 3612265
Neurosurgery. 1981 Nov;9(5):506-13
pubmed: 7322311
Neurosurgery. 1980 Jan;6(1):1-9
pubmed: 7354892

Auteurs

Qingyuan Liu (Q)

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.
China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People's Republic of China.
Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, People's Republic of China.

Pengjun Jiang (P)

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.
China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People's Republic of China.
Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, People's Republic of China.

Jun Wu (J)

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.
China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People's Republic of China.

Maogui Li (M)

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.
China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People's Republic of China.

Bin Gao (B)

School of Life Science and BioEngineering, Beijing University of Technology, Beijing, 100124, People's Republic of China.

Yanan Zhang (Y)

Department of Blood Transfusion, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.

Bo Ning (B)

Department of Neurosurgery, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, 510220, Guangdong, People's Republic of China.

Yong Cao (Y)

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.
China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People's Republic of China.

Shuo Wang (S)

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China. captain9858@126.com.
China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China. captain9858@126.com.
Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People's Republic of China. captain9858@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH